Orchard Therapeutics
UKEntry
2017
Hold
1yr
Exit
2018
Who owns Orchard Therapeutics?
Orchard Therapeutics was owned by 4Bio Partners through 4BIO Ventures III (2022 vintage) from 2017 to 2018, exited via IPO.
Hand-verified · updated 2026-07-08
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2018
More from 4BIO Ventures III
Other portfolio companies in the same fund.
Switzerland
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Orchard Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Orchard Therapeutics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Orchard Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue